Platteville Podiatry, Llc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 915 E Mineral St, Platteville, WI 53818 Phone: 608-348-7688 Fax: 608-348-7687 |
Dr. Joan Marie Harrington, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 915 E Mineral St, Platteville, WI 53818 Phone: 160-834-8768 Fax: 160-834-8768 |
Dr. Scott Holden Kjar, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 915 E Mineral St, Platteville, WI 53818 Phone: 160-834-8768 Fax: 160-834-8768 |
News Archive
Researchers say that patients undergoing laparoscopic hysterectomy can be discharged the same day, with no associated safety concerns.
The government's health watchdog in Britain, the Healthcare Commission says patients with learning difficulties receive standards of care which are well below what should be expected of modern healthcare services.
People are using brain-machine interfaces to restore motor function in ways never before possible - through limb prosthetics and exoskletons. But technologies to repair and improve cognition have been more elusive. That is rapidly changing with new tools - from fully implantable brain devices to neuron-eavesdropping grids atop the brain - to directly probe the mind.
Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in women with platinum-resistant/refractory ovarian cancer. A total of 68 patients were enrolled with platinum-resistant disease, half of whom were platinum refractory. All 68 patients were evaluable for the primary endpoint of objective response rate using Gynecologic Cancer InterGroup criteria, which is a combination of response by tumor imaging (RECIST) and/or ovarian cancer biomarker (CA-125) criteria.
Abingworth, the international investment group dedicated to life sciences and healthcare, today announced the final closing of its £225m ($375m) fund, Abingworth Bioventures VI (ABV VI). ABV VI, Abingworth's 10th life sciences fund, exceeded its target of £200 million and invests in life sciences and healthcare both in Europe and the US.
› Verified 4 days ago